Vertex CEO urges May to intervene in U.K. standoff

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) Chairman, CEO and President Jeff Leiden sent a letter Friday requesting that U.K. Prime Minister Theresa May intervene in a stalemate over cystic fibrosis drug Orkambi lumacaftor/ivacaftor and warning that investment in U.K.

Read the full 378 word article

User Sign In